Xylazine and Opioid Use: An Update
Event Date
Event Host
***This event is not sponsored by RCORP-TA. Please reach out directly to the event organizers with any questions.***
The urgency of the opioid crisis that began in 2019 has not abated and fentanyl continues to fuel the overdose rates. More recently, an emerging trend has been identified. Yet another dangerous substance called Xylazine has been found more frequently in various illicit substances and is worsening outcomes for people who use opioids.
This webinar, held by the Northeast and Caribbean PTTC, is intended to provide the latest information available on Xylazine, including associated effects on the body and long-term impacts on opioid users, and review current organizational strategies to help prevent exacerbated and related harm.
Trainer
Diana Padilla, MCPC, CARC, CASAC-T, is a Research Project Manager at New York State Psychiatric Institute, Columbia University Medical Center. She is a senior staff trainer for the Northeast & Caribbean Addiction Transfer Technology Center Network (NeC-ATTC), and a member of the ASAP-NYCB Trainer Registry. As a cultural agent, Ms. Padilla promotes an equity lens in trainings for engaging diverse communities in need, aligning with evidence and strength-based strategies within behavioral health, addiction, prevention, and recovery supports fields and professional capacities.